| Lingual toothbrush |
17480 |
Standard |
30/11/1999 |
Ergonomic Dental Technologies, Inc. |
| Method of use of a disposable nonwoven substrate |
17481 |
Standard |
30/11/1999 |
Procter & Gamble Company, The |
| Promotion or inhibition of angiogenesis and cardiovascularization |
17482 |
Standard |
30/11/1999 |
Genentech Inc. |
| Diagnosis of stage or aggressiveness of cancer |
17483 |
Standard |
30/11/1999 |
Wrair Walter Reed Army Institute of Research |
| Nucleic acids and polypeptides of (d. melanogaster) insulin-like genes and uses thereof |
17484 |
Standard |
30/11/1999 |
Exelixis Pharmaceuticals, Inc. |
| Fiber optic difference current sensor |
17485 |
Standard |
30/11/1999 |
Honeywell Inc. |
| Method and apparatus for handset audible zone and number indication |
17486 |
Standard |
30/11/1999 |
GTE Wireless Service Corporation |
| Configuration programming of input/output connections for network modules in a multiplexed vehicle communication system |
17487 |
Standard |
29/11/1999 |
International Truck and Engine Corporation |
| Treatment of disorders secondary to organic impairments |
17488 |
Standard |
01/12/1999 |
Mueller, Peter Sterling |
| Maneuverable fetal vacuum extractor for use with malpresenting fetus |
17489 |
Standard |
30/11/1999 |
Clinical Innovations Limited |
| Substrates for forming synthetic tissues |
17490 |
Standard |
30/11/1999 |
St. Jude Medical Inc. |
| 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
17491 |
Standard |
01/12/1999 |
Bristol-Myers Squibb Company |
| Thermoplastic fibers and fabrics |
17492 |
Standard |
02/12/1999 |
Dow Global Technologies Inc. |
| Bismuth oxide catalyst for cathodic electrocoating compositions |
17493 |
Standard |
02/12/1999 |
E.I. Du Pont De Nemours and Company |
| Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs |
17494 |
Standard |
02/12/1999 |
Temple University - of The Commonwealth System of Higher Education |
| Germanium bridged metallocenes producing polymers with increased melt strength |
17495 |
Standard |
02/12/1999 |
Univation Technologies LLC |
| Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
17496 |
Standard |
02/12/1999 |
General Hospital Corporation, The |
| Methods and articles for regenerating living tissue |
17497 |
Standard |
02/12/1999 |
Gore Enterprise Holdings, Inc. |
| Methods and compositions for inhibiting neoplastic cell growth |
17498 |
Standard |
02/12/1999 |
Genentech Inc. |
| Methods and compositions for inhibiting neoplastic cell growth |
17499 |
Standard |
02/12/1999 |
Genentech Inc. |